{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2024:P62XQBAL4B6AQBU3NLILKQF6T2","short_pith_number":"pith:P62XQBAL","schema_version":"1.0","canonical_sha256":"7fb578040be07c08069b6ad0b540be9eb5f902bd27c70eddc42f39dbb2aa2d7d","source":{"kind":"arxiv","id":"2406.03403","version":1},"attestation_state":"computed","paper":{"title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.AI","q-bio.QM"],"primary_cat":"cs.LG","authors_text":"Kangyu Zheng, Marinka Zitnik, Tianfan Fu, Yao Ma, Yingzhou Lu, Zaixi Zhang, Zhongwei Wan","submitted_at":"2024-06-04T15:37:14Z","abstract_excerpt":"Currently, the field of structure-based drug design is dominated by three main types of algorithms: search-based algorithms, deep generative models, and reinforcement learning. While existing works have typically focused on comparing models within a single algorithmic category, cross-algorithm comparisons remain scarce. In this paper, to fill the gap, we establish a benchmark to evaluate the performance of sixteen models across these different algorithmic foundations by assessing the pharmaceutical properties of the generated molecules and their docking affinities with specified target protein"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2406.03403","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.LG","submitted_at":"2024-06-04T15:37:14Z","cross_cats_sorted":["cs.AI","q-bio.QM"],"title_canon_sha256":"753f54bf5e83183f59e8f1a6cb189892274209fd3255d4119a3c9e29da76995d","abstract_canon_sha256":"1d04c59729383e3c599dea8494bf5514a0f5447ec9d1b109943007e313612da8"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T08:27:56.101607Z","signature_b64":"Mbo1R+fGvewGjwgjqkhfSi+fQmx2vGH2JngKkaQprpptjxGl7/UKWk0WOz4wJp73S0HXGaRwFOdn0v1QBKDXCA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"7fb578040be07c08069b6ad0b540be9eb5f902bd27c70eddc42f39dbb2aa2d7d","last_reissued_at":"2026-07-05T08:27:56.101038Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T08:27:56.101038Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.AI","q-bio.QM"],"primary_cat":"cs.LG","authors_text":"Kangyu Zheng, Marinka Zitnik, Tianfan Fu, Yao Ma, Yingzhou Lu, Zaixi Zhang, Zhongwei Wan","submitted_at":"2024-06-04T15:37:14Z","abstract_excerpt":"Currently, the field of structure-based drug design is dominated by three main types of algorithms: search-based algorithms, deep generative models, and reinforcement learning. While existing works have typically focused on comparing models within a single algorithmic category, cross-algorithm comparisons remain scarce. In this paper, to fill the gap, we establish a benchmark to evaluate the performance of sixteen models across these different algorithmic foundations by assessing the pharmaceutical properties of the generated molecules and their docking affinities with specified target protein"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2406.03403","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2406.03403/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2406.03403","created_at":"2026-07-05T08:27:56.101108+00:00"},{"alias_kind":"arxiv_version","alias_value":"2406.03403v1","created_at":"2026-07-05T08:27:56.101108+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2406.03403","created_at":"2026-07-05T08:27:56.101108+00:00"},{"alias_kind":"pith_short_12","alias_value":"P62XQBAL4B6A","created_at":"2026-07-05T08:27:56.101108+00:00"},{"alias_kind":"pith_short_16","alias_value":"P62XQBAL4B6AQBU3","created_at":"2026-07-05T08:27:56.101108+00:00"},{"alias_kind":"pith_short_8","alias_value":"P62XQBAL","created_at":"2026-07-05T08:27:56.101108+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":1,"internal_anchor_count":1,"sample":[{"citing_arxiv_id":"2502.05107","citing_title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","ref_index":92,"is_internal_anchor":true}]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2","json":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2.json","graph_json":"https://pith.science/api/pith-number/P62XQBAL4B6AQBU3NLILKQF6T2/graph.json","events_json":"https://pith.science/api/pith-number/P62XQBAL4B6AQBU3NLILKQF6T2/events.json","paper":"https://pith.science/paper/P62XQBAL"},"agent_actions":{"view_html":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2","download_json":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2.json","view_paper":"https://pith.science/paper/P62XQBAL","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2406.03403&json=true","fetch_graph":"https://pith.science/api/pith-number/P62XQBAL4B6AQBU3NLILKQF6T2/graph.json","fetch_events":"https://pith.science/api/pith-number/P62XQBAL4B6AQBU3NLILKQF6T2/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2/action/timestamp_anchor","attest_storage":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2/action/storage_attestation","attest_author":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2/action/author_attestation","sign_citation":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2/action/citation_signature","submit_replication":"https://pith.science/pith/P62XQBAL4B6AQBU3NLILKQF6T2/action/replication_record"}},"created_at":"2026-07-05T08:27:56.101108+00:00","updated_at":"2026-07-05T08:27:56.101108+00:00"}